+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Labetalol in the treatment of hypertension in elderly and younger patients



Labetalol in the treatment of hypertension in elderly and younger patients



Journal of Clinical Pharmacology 27(11): 902-906



The efficacy and safety of labetalol therapy were evaluated in 20 patients 60 years and older with isolated systolic or diastolic hypertension and 19 patients aged younger than 60 years with diastolic hypertension. After a two-week placebo washout period, labetalol was titrated for up to four weeks (100-400 mg bid) until blood pressure control was achieved (standing systolic less than 160 mm Hg or greater than or equal to 10% reduction from baseline, and standing diastolic less than 90 mm Hg or a decrease of 10 mm Hg from baseline). Mean decreases in standing systolic and diastolic blood pressure from baseline were statistically significant for both age groups (greater than or equal to 60 years, -23/-13; less than 60 years, -18/-12, P less than .01). Control criteria were met in 18 (90%) older and 15 (79%) younger patients who then entered a four-week maintenance period. Sixteen (80%) of the older patients and six (32%) of the younger patients maintained blood pressure control on 200 mg or less of labetalol bid (P less than .05). Three patients, two of whom withdrew from the study, were judged to have experienced adverse events that were drug related. It was concluded that labetalol was effective and well-tolerated antihypertensive therapy in both elderly and younger patients. In addition, significantly less medication was required to achieve blood pressure control in the elderly.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 005787157

Download citation: RISBibTeXText

PMID: 2892866

DOI: 10.1002/j.1552-4604.1987.tb05586.x


Related references

Labetalol in the treatment of elderly patients with mild essential hypertension. Journal of the American Osteopathic Association 88(3): 359-364, 1988

Treatment of hypertension in the elderly with labetalol. PharmacoTherapy 9(5): 295-302, 1989

Treatment of essential hypertension in the elderly with labetalol. Japanese Archives of Internal Medicine 34(12): 459-466, 1987

Delapril in the treatment of essential hypertension an equipotent antihypertensive effect in elderly hypertensives and younger patients. Current Therapeutic Research 50(3): 363-368, 1991

Treatment of isolated systolic hypertension with labetalol in the elderly. Archives of Internal Medicine 150(5): 974-976, 1990

Isolated systolic hypertension ish in the elderly treatment with labetalol. Journal of Clinical Pharmacology 28(10): 921, 1988

Evaluation of labetalol in elderly patients with essential hypertension. Journal of Clinical Pharmacology 31(6): 556-560, 1991

A combination of labetalol and flunarizine in the treatment of arterial hypertension in the elderly. Clinical Trials Journal 21(6): 403-410, 1984

Comparison of labetalol as a single treatment and labetalol combined with chlorthalidone in the treatment of severe arterial hypertension. Bollettino Chimico Farmaceutico 127(11-12): 71s, 1988

Comparison in young and elderly patients of pharmacodynamics and disposition of labetalol in systemic hypertension. American Journal of Cardiology 60(8): 697-702, 1987

A double blind comparison between labetalol and clonidine in the treatment of hypertension in the elderly a multicenter study. Therapie (London/Paris) 42(3): 277-284, 1987

Comparison of labetalol and hydrochlorothiazide in elderly patients with hypertension using 24-hour ambulatory blood pressure monitoring. Journal of Clinical Pharmacology 30(6): 524-532, 1990

Treatment of hypertension with labetalol in neurosurgical practice. Influence of labetalol on cerebral perfusion pressure in dogs without and with intracranial mass lesions. Acta Neurochirurgica 67(3-4): 283-290, 1983

Comparison of labetalol versus enalapril as monotherapy in elderly patients with hypertension results of 24 hour ambulatory blood pressure monitoring. American Journal of Medicine 90(2): 198-205, 1991

Labetalol treatment of patients with arterial hypertension. Vrachebnoe Delo: 35-37, 1988